Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rare Earth Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115044052B reveals recyclable rare earth MOF catalyst for solvent-free silylcyanation. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN105837544B details a rare earth catalyzed synthesis offering high purity and environmental safety for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN105837544B details a green synthesis route for coumarin derivatives using rare earth catalysts, offering supply chain stability and cost efficiency.
Patent CN108250236B reveals a novel ytterbium catalyst for efficient, solvent-free synthesis of alpha-hydroxy phosphates, offering significant cost and supply chain advantages.
Patent CN108164555B reveals a high-efficiency rare earth catalyst for boronic ester synthesis, offering mild conditions and significant cost reduction in fine chemical manufacturing.
Patent CN103613551A details a novel rare earth-catalyzed route for 1,5-disubstituted-1,2,3-triazoles, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Innovative rare earth metal cluster catalysis enables solvent-free amide synthesis with high yields and broad substrate scope enhancing supply chain reliability for pharmaceutical intermediates
Solve sesamin precursor synthesis challenges with this rare earth metal method. 60-90% yield, air-stable operation, and reduced supply chain risks for pharma R&D and production.